QA: Cytodyn Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001175680_2023_Cytodyn_Inc.pdf

Logs

Graph

Absolute values for 0001175680, Cytodyn Inc

  xvar xval
0 AssetsCurrent 10,515,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 18,670,000
4 LiabilitiesCurrent 123,161,000
5 LiabilitiesNoncurrent 422,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 53,000
8 SellingGeneralAndAdministrativeExpense 93,795,292
9 ResearchAndDevelopmentExpense 23,289,733
10 remainder_Expenses 339,173,709
11 remainder_Revenues 120,195
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 29,185,000
1 Liabilities 123,583,000
2 Expenses 456,311,734
3 Revenues 120,195
4 StockholdersEquity -94,398,000
5 NetIncome -456,191,539
6 ComprehensiveNetIncome -456,191,539
7 BaseVar 304,599,964
8 EconomicCapitalRatiobeforeLimitedLiability -8.67
9 EconomicCapitalRatio 0.00347

Edgar->Model Mapping

Feature Distribution

Change over Time